AMYLIN PHARMACEUTICALS INC 4
4 · AMYLIN PHARMACEUTICALS INC · Filed Jun 4, 2007
Insider Transaction Report
Form 4
EBERHARD CRAIG A
VP Sales
Transactions
- Exercise/Conversion
Common Stock
2007-06-01$18.85/sh+2,000$37,700→ 25,747 total - Sale
Common Stock
2007-06-01$46.00/sh−2,000$91,999→ 23,747 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2007-06-01−2,000→ 7,800 totalExercise: $18.85Exp: 2013-05-12→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]5,825 options vested on 05/12/04, and monthly after that, until all the 23,300 options were completely vested on 05/12/07.